-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at BofA Securities
-
-
-
-
-
-
-
Wolfe Research Starts Acadia Pharmaceuticals (ACAD) at Outperform
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Stifel
-
-
-
-
-
-
-
ACADIA Pharmaceuticals board member Daniel Soland resigns
-
-
-
-
-
-
-
Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at TD Cowen
-
-
-
-
-
-
-
Stifel on Soleno Therapeutics Inc. (SLNO): 'we remain bullish and believe Vykat is well-positioned for significant/sustained growth'
-
413,422 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

